Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002210125 | SCV002365887 | likely benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2023-11-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004734427 | SCV005358583 | uncertain significance | RTEL1-related disorder | 2024-09-28 | no assertion criteria provided | clinical testing | The RTEL1 c.449C>T variant is predicted to result in the amino acid substitution p.Thr150Met. This variant was reported in two large cohorts with developmental disorders (Table S1, Kaplanis et al. 2020. PubMed ID: 33057194; Supplementary Data 3, Zhou et al. 2022. PubMed ID: 35982159). This variant is reported in 0.0066% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |